C. Daniel Mullins, PhD, honored with Avedis Donabedian Outcomes Research Award for 30-year career focused on improving health outcomes.

The School of Pharmacy’s director of human resources is honored for her hard work, dedication, innovation, and ability to mix excellence with empathy.

Andrew Coop, PhD, a medicinal chemist with expertise in the pharmacology of psychedelics, will lead an effort to explore pathways for the safe, accessible, and equitable use of natural psychedelics.

Kimberly Claeys, PharmD, PhD, an infectious disease pharmacist, will lead a multidisciplinary team focused on incorporating the 4Ms of age-friendly care to improve clinician workflow and patient outcomes in older adults with suspected UTI.

Two-year grant aims to evaluate how COVID-19 pandemic policies affected medication treatment, outcomes, and costs for youth with ADHD.

Joga Gobburu, PhD, MBA, MSc, is a trailblazer in the field of translational medicine, which integrates knowledge across experiments and clinical trials to lay the groundwork for strategic decisions on drug regulation and/or drug development and precision medicine.

Lauren Hynicka teaches electives on integrative medicine and culinary medicine and nutrition.

Megan Ehret specializes in psychiatric pharmacy.

James Polli and Lisa Lebovitz received honors at the AACP Annual Meeting in July.

Eberechukwu Onukwugha is a professor of practice, sciences, and health outcomes research.

Cherokee Layson-Wolf received the Pharmacist Advocate Award, and Amy Howard received the Excellence in Innovation Award.

The advisory board received UMB’s Catalyst of Excellence Award.